Web-based Weight Loss Intervention

June 2, 2020 updated by: 23andMe, Inc.
Excess weight is a major risk factor underlying leading causes of death globally, including cardiovascular disease, type 2 diabetes, and some cancers. Among participants assigned to the same lifestyle intervention arms in prior weight loss randomized controlled trials, large inter-individual differences in weight loss success have been observed, ranging from >50lbs of weight loss to >10lbs of weight gain. Both genetic and non-genetic factors underlying differential adherence and weight loss success are poorly understood.

Study Overview

Detailed Description

23andMe aims to recruit 91,227 adults to participate in a web-based weight loss intervention. Primary aims include: a.) to confirm whether AG/GG individuals at MTIF3 rs1885988 lose more weight on lifestyle interventions; and b.) to test the performance of a randomized controlled trial vs. self-selection study design in terms of weight loss, drop-outs, and adherence. Secondary (exploratory) analyses will focus on discovery of genetic and non-genetic predictors of weight loss success overall, and examination of potential interactions by intervention type. Web-administered intervention content, videos, and forums will be surfaced to participants every two weeks, and self-reported surveys will be surfaced weekly for the active intervention duration.

Study Type

Interventional

Enrollment (Actual)

63656

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Mountain View, California, United States, 94041
        • 23andMe
      • Mountain View, California, United States, 94043
        • 23andMe

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 66 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • US-based men and women in self-reported 'good' or better health
  • Consented to participate in research
  • BMI 25-40 kg/m2
  • Not actively on a weight loss plan
  • Willing and able to modify eating and physical activity patterns
  • Not under a doctor's care for a serious medical condition

Exclusion Criteria:

  • Are pregnant, lactating, within 6 months postpartum, or planning to become pregnant in the next 6 months
  • Have diabetes (type 1 or 2) or are on hypoglycemic medications
  • Had a heart attack or stroke within the past year
  • Are unable or unwilling to follow a physical activity or diet intervention due to a medical condition or doctor's orders
  • Have an eating disorder
  • Have severe depression, anxiety, or other psychiatric conditions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Randomized- Lower carbohydrate diet
Focused on limiting dietary carbohydrates, eating healthy fat and protein sources, and engaging in physical activity
Experimental: Randomized- Higher fiber diet
Focused on increasing dietary fiber, lowering fat intake from animal sources, and engaging in physical activity
Experimental: Randomized- Exercise focused
Focused on aerobic and resistance exercise, while following dietary guidelines
Experimental: Participant chooses- Lower carbohydrate diet
Focused on limiting dietary carbohydrates, eating healthy fat and protein sources, and engaging in physical activity
Experimental: Participant chooses- Higher fiber diet
Focused on increasing dietary fiber, lowering fat intake from animal sources, and engaging in physical activity
Experimental: Participant chooses- Exercise focused
Focused on aerobic and resistance exercise, while following dietary guidelines

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in weight from week 1 to week 12 of intervention
Time Frame: 12 weeks
12 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Change in waist circumference from week 1 to week 12 of intervention
Time Frame: 12 weeks
12 weeks
Change in waist-to-hip ratio from week 1 to week 12 of intervention
Time Frame: 12 weeks
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Geoffrey Benton, PhD, 23andMe, Inc.
  • Study Director: Liana Del Gobbo, PhD, 23andMe, Inc.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 27, 2017

Primary Completion (Actual)

January 8, 2019

Study Completion (Actual)

April 16, 2019

Study Registration Dates

First Submitted

January 4, 2018

First Submitted That Met QC Criteria

January 9, 2018

First Posted (Actual)

January 17, 2018

Study Record Updates

Last Update Posted (Actual)

June 4, 2020

Last Update Submitted That Met QC Criteria

June 2, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 23andMe_WLI001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overweight and Obesity

Clinical Trials on Lower carbohydrate diet

Subscribe